One hundred years of the St Mark’s hospital polyposis registry.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00463-x
- By:
- Publication type:
- Article
Works matching IS 13899600 AND DT 2025 AND VI 24 AND IP 2
Results: 12
1
2
A review of APC somatic mosaicism and specific APC variants - I1307K and promotor variants.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00464-w
- By:
- Publication type:
- Article
3
Genetics, genomics and clinical features of adenomatous polyposis.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00460-0
- By:
- Publication type:
- Article
4
Causes of DNA mismatch repair deficiency in sebaceous skin lesions demonstrating loss of MLH1 protein expression: constitutional over somatic MLH1 promoter methylation.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00456-w
- By:
- Publication type:
- Article
5
Guidelines for Familial Adenomatous Polyposis (FAP): challenges in defining clinical management for a rare disease.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00462-y
- By:
- Publication type:
- Article
6
Correction: The genetic landscape of Lynch syndrome in the Israeli population.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
7
Azacitidine and venetoclax for the treatment of AML arising from an underlying telomere biology disorder: Azacitidine and venetoclax for the treatment of AML…: A. Pandey et al.
- Published in:
- 2025
- By:
- Publication type:
- Letter
8
The current status of care for families with Lynch syndrome in China.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00452-0
- By:
- Publication type:
- Article
9
Endometrial thickness among BRCA mutation carriers undergoing prophylactic oophorectomy.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00458-8
- By:
- Publication type:
- Article
10
The patterns and spectrum of BRCA1 and BRCA2 mutations in Iranian breast and ovarian cancer patients.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00459-7
- By:
- Publication type:
- Article
11
The European Reference Network on Genetic Tumour Risk Syndromes (ERN GENTURIS): benefits for patients, families, and health care providers.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00457-9
- By:
- Publication type:
- Article
12
Non-serous ovarian cancer in PTEN Hamartoma Tumor Syndrome: additional evidence for increased risk: Non-serous ovarian cancer: A. J. Schei-Andersen et al.
- Published in:
- Familial Cancer, 2025, v. 24, n. 2, p. 1, doi. 10.1007/s10689-025-00453-z
- By:
- Publication type:
- Article